Reducing Alcohol Exposed Pregnancies

Sponsor
New York University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05766761
Collaborator
The University of Texas Health Science Center, Houston (Other), Health Resources in Action, Inc. (Other), Purdue University (Other)
600
1
2
39.9
15

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare an active intervention versus a standard of care control in reducing alcohol use among pregnant women. The main questions it aims to answer are whether a motivational intervention can:

  1. increase the proportion of women detected with a laboratory-confirmed negative PEth test during pregnancy, and

  2. reduce the proportion of adverse birth outcomes among infants. Participants will be offered (1) a self-paced computer-delivered alcohol reduction intervention to enhance knowledge, norms, and motivation for alcohol reduction and (2) a nurse-delivered component to reinforce the computer-delivered content and address women's questions. Both components are theory-driven, based on Motivational Enhancement Theory (MET), and use motivational strategies to promote alcohol reduction.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention condition, the usual prenatal care plus the alcohol intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Eligible women are randomized to either (1) the intervention condition, the usual prenatal plus the alcohol intervention, or (2) the comparison condition, usual prenatal care only.Eligible women are randomized to either (1) the intervention condition, the usual prenatal plus the alcohol intervention, or (2) the comparison condition, usual prenatal care only.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Designing a Hybrid Intervention Strategy to Reduce Alcohol Exposed Pregnancies
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Sep 1, 2026
Anticipated Study Completion Date :
Apr 30, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention condition, the usual prenatal care plus the alcohol intervention

The alcohol intervention consists of (1) a self-paced computer-delivered component to enhance knowledge, norms, and motivation for alcohol reduction and (2) a nurse-delivered component to reinforce the computer-delivered content and address women's questions.

Behavioral: Intervention condition, the usual prenatal care plus the alcohol intervention
The intervention is theory-driven, based on Motivational Enhancement Theory (MET), and uses motivational strategies to promote alcohol reduction.

No Intervention: Comparison condition, usual prenatal care only

Prenatal usual care involves clinicians assessing alcohol use and counseling women on alcohol-related risks.

Outcome Measures

Primary Outcome Measures

  1. Negative PEth among women [Through study completion, on average 6 months post-enrollment]

    Proportion of women detected with a laboratory-confirmed negative PEth test during pregnancy

Secondary Outcome Measures

  1. Pre-term births [At birth]

    Proportion of infants whose gestational age is <37 weeks

  2. Low birth weight [At birth]

    Proportion of infants who weighed less than 2500 grams at birth

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years and above

  • Gestational age is 8 weeks or less

  • Recent alcohol use as assessed by a positive EtG or self-report of alcohol use in the previous 21 days

Exclusion Criteria:
  • Under 18 years of age

  • Not pregnant or gestational age over 8 weeks

  • No recent alcohol use

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center, Houston Houston Texas United States 77030

Sponsors and Collaborators

  • New York University
  • The University of Texas Health Science Center, Houston
  • Health Resources in Action, Inc.
  • Purdue University

Investigators

  • Principal Investigator: Ralph DiClemente, PhD, New York University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
New York University
ClinicalTrials.gov Identifier:
NCT05766761
Other Study ID Numbers:
  • 1U01AA030187-01
First Posted:
Mar 13, 2023
Last Update Posted:
Mar 13, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by New York University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 13, 2023